Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
Publication
, Conference
Levis, M; Ravandi, F; Wang, ES; Baer, MR; Perl, A; Coutre, S; Erba, H; Stuart, RK; Baccarani, M; Cripe, LD; Tallman, MS; Meloni, G; Lewis, ID ...
Published in: BLOOD
November 20, 2009
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
325 / 326
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting and Exposition of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levis, M., Ravandi, F., Wang, E. S., Baer, M. R., Perl, A., Coutre, S., … Smith, B. D. (2009). Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse. In BLOOD (Vol. 114, pp. 325–326). New Orleans, LA: AMER SOC HEMATOLOGY.
Levis, Mark, Farhad Ravandi, Eunice S. Wang, Maria R. Baer, Alexander Perl, Steven Coutre, Harry Erba, et al. “Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.” In BLOOD, 114:325–26. AMER SOC HEMATOLOGY, 2009.
Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, et al. Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse. In: BLOOD. AMER SOC HEMATOLOGY; 2009. p. 325–6.
Levis, Mark, et al. “Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.” BLOOD, vol. 114, no. 22, AMER SOC HEMATOLOGY, 2009, pp. 325–26.
Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Jedrzejczak WW, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD. Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse. BLOOD. AMER SOC HEMATOLOGY; 2009. p. 325–326.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
325 / 326
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting and Exposition of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology